SLAM
INBX icon

Swiss Life Asset Management’s Inhibrx INBX Stock Holding History

Swiss Life Asset Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$274K Buy
+7,714
New +$572K ﹤0.01% 1174

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Swiss Life Asset Management's INBX Position: Q1 2026 in Review

Swiss Life Asset Management opened a new position in Inhibrx (INBX) in Q1 2026: 7,714 shares worth $274K. The stake represents ﹤0.01% of the portfolio and ranks #1174 among its holdings.

135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Swiss Life Asset Management held 7,714 shares of Inhibrx worth $274K as of Q1 2026.
  • Inhibrx was a new Swiss Life Asset Management position in Q1 2026.
  • Inhibrx made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q1 2026, its #1174 holding.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Swiss Life Asset Management's 13F filing for Q1 2026, filed 14 May 2026.